DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Chembio Diagnostics, Inc. (CEMI)
« Back to company indexCEMI Chatter Timeline
Stock Ticker for CEMI
Most Active Tweeters for CEMI
| User | Tweets |
|---|---|
| @smallcapwatch | 6 |
| @mmahotstuff1 | 4 |
| @whatsonthorold2 | 3 |
| @TickerReport | 2 |
| @WeekHerald | 2 |
Recent Tweets for CEMI
 |
@tzack16 $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/fOPbzarh7n March 21st 2019, 10:03pm |
 |
@mmahotstuff1 Chembio Diagnostics Inc $CEMI's Stock Is Buy After Less Market Selling https://t.co/afPLjdW5wN March 21st 2019, 12:03pm |
 |
@whatsonthorold2 Chembio Diagnostics Inc $CEMI's Stock Is Buy After Less Market Selling https://t.co/Y7huzx1RqV March 21st 2019, 12:03pm |
 |
@bibeypost_stock What Next for Chembio Diagnostics Inc $CEMI Stock After Decrease in Shorted Shares? https://t.co/WJBHaJe79W March 21st 2019, 12:03pm |
 |
@reurope_stock Could Chembio Diagnostics Inc $CEMI Go Down After Its Newest Short Interest Report? https://t.co/p6ektFmCdl March 21st 2019, 12:03pm |
 |
@TheTruthStudio $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/yKKUnTPPGj March 21st 2019, 7:03am |
 |
@RockPaperMoon RT @zackcapp: $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point https://t.co/XBtHxY15vh $… March 20th 2019, 6:03pm |
 |
@zackcapp $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/WSrVHrbBlL March 20th 2019, 6:03pm |
 |
@smallcapwatch RT @InstitutionalZC: $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point https://t.co/yafpi… March 20th 2019, 5:03pm |
 |
@InstitutionalZC $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/oLlcb6u9an March 20th 2019, 5:03pm |
|
@smallcapwatch RT @AnalystsAnalyst: $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point https://t.co/xjx0C… March 20th 2019, 12:03pm |
 |
@AnalystsAnalyst $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/30CYA4wOxS March 20th 2019, 12:03pm |
 |
@ZacksAwareness $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/3ZP5QLvJbJ March 20th 2019, 10:03am |
|
@smallcapwatch RT @ahighelevation: $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point https://t.co/95PTRX… March 20th 2019, 5:03am |
 |
@ahighelevation $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/O6JNNnLQYW March 20th 2019, 5:03am |
|
@smallcapwatch RT @ContentCarnivor: $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point https://t.co/8WSs9… March 20th 2019, 12:03am |
 |
@ContentCarnivor $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/dhRP0tduxt March 20th 2019, 12:03am |
|
@smallcapwatch RT @zackcappsocial: $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point https://t.co/8w04tS… March 19th 2019, 10:03pm |
 |
@zackcappsocial $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/o2zwirVOS3 March 19th 2019, 10:03pm |
|
@smallcapwatch RT @HowieRegay: $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point https://t.co/2lthMWwnub… March 19th 2019, 4:03pm |
 |
@HowieRegay $CEMI Revenue, margin guidance and historical context indicates this could be opportune entry point… https://t.co/YwGoc6HDpt March 19th 2019, 4:03pm |
 |
@StockTexts $CEMI Chembio Diagnostics, Inc. SEC Filing: Form 10-K https://t.co/T7vC1ZPWKG March 18th 2019, 6:03am |
 |
@BlogYomi Chembio Diagnostics $CEMI Gets BidaskScore Lower Rating; KION GROUP AG ORDINARY SHARES GERMANY $KNNGF Sellers Incre… https://t.co/w8GYhCouNS March 17th 2019, 6:03am |
|
@mmahotstuff1 BidaskScore Has Just Given Chembio Diagnostics $CEMI a Lower Rating. Are Other Analysts Next? https://t.co/wgskDwQ8Kg March 16th 2019, 12:03am |
|
@whatsonthorold2 Is Chembio Diagnostics $CEMI Worth Your Time and Dime After a BidaskScore Downgrade? https://t.co/0iyOZgCidZ March 16th 2019, 12:03am |
|
@bibeypost_stock BidaskScore Hits Chembio Diagnostics $CEMI Hard With Today’s Downgrade https://t.co/ylzrR8adCn March 16th 2019, 12:03am |
|
@reurope_stock Chembio Diagnostics $CEMI Seems to Be a Stock That BidaskScore Is a Bit Wary of; Firm Downgrades Shares https://t.co/xpABnD7Bis March 16th 2019, 12:03am |
 |
@ResearchPool $CEMI #Chembio Diagnostics Inc. CEMI: Revenue, margin guidance and historical context indicates this could be oppor… https://t.co/kQJXvA9Geh March 15th 2019, 9:03pm |
 |
@SwingTradeBot Recent $CEMI technical alerts: Lower Bollinger Band Walk plus 8 more alerts... https://t.co/JkYHwjAPcF March 15th 2019, 12:03pm |
 |
@1MinuteStock Wondering about #sentiment indicator for $CEMI? The Short Ratio is 1.64% https://t.co/isntWisVyk March 15th 2019, 11:03am |
|
@mmahotstuff1 After Reaching Milestone, Is Chembio Diagnostics Inc $CEMI’s Short Interest Revealing Something? https://t.co/zSyIlqAXur March 14th 2019, 2:03pm |
|
@whatsonthorold2 What's Chembio Diagnostics Inc $CEMI Upside After This Short Interest Decrease? https://t.co/RaX6VVrBfo March 14th 2019, 2:03pm |
 |
@dispatchtribune Chembio Diagnostics $CEMI Receives Buy Rating from Canaccord Genuity https://t.co/OhJjba3NST March 14th 2019, 3:03am |
 |
@WeekHerald Chembio Diagnostics Inc $CEMI Expected to Announce Earnings of -$0.12 Per Share https://t.co/xHPFc0BKmN March 13th 2019, 11:03am |
 |
@TickerReport Chembio Diagnostics $CEMI Stock Rating Reaffirmed by Canaccord Genuity https://t.co/jnonDbpIl8 March 13th 2019, 3:03am |
 |
@dailypoliticaln Chembio Diagnostics $CEMI Stock Rating Reaffirmed by Canaccord Genuity https://t.co/8K3tONHnR1 March 13th 2019, 3:03am |
 |
@dakotafinancial Brokers Issue Forecasts for Chembio Diagnostics Inc’s Q1 2019 Earnings $CEMI https://t.co/kYPWzDzTyB March 13th 2019, 1:03am |
 |
@FinZTribune Buy rating was Reaffirmed at Canaccord Genuity. Chembio Diagnostics $CEMI Has Given Price Objective Of $9. https://t.co/rXXQ2ZrPpy March 12th 2019, 11:03am |
 |
@thefinreviewer Braun Stacey Associates Holds Position in Procter & Gamble Company $PG; Chembio Diagnostics $CEMI Shares Rose While… https://t.co/vKj9QiD7kF March 11th 2019, 10:03am |
|
@mmahotstuff1 Today Canaccord Genuity Maintains a "Buy" Rating on Chembio Diagnostics $CEMI and a $9 Target Price https://t.co/rhBfCj1Znk March 11th 2019, 9:03am |
 |
@marketexclusive $CEMI Chembio Diagnostics Inc (NASDAQ:CEMI) had its Buy rating reiterated by Canaccord Genuity with a $9.00 price… https://t.co/nQqdwRKqqw March 11th 2019, 8:03am |
 |
@RatingsNetwork Dougherty & Co Sets Chembio Diagnostics Q1 2019 Earnings Estimates at ($0.12) EPS. https://t.co/yfPTP6Z7dO $CEMI #CEMI March 11th 2019, 1:03am |
|
@BlogYomi Longwood Capital Partners Has Cut Holding in Chembio Diagnostics $CEMI by $8.22 Million as Market Valuation Rose; T… https://t.co/cLPdcEpjkN March 9th 2019, 3:03pm |
|
@WeekHerald Chembio Diagnostics $CEMI Releases Earnings Results, Misses Estimates By $0.04 EPS https://t.co/vZMOnIvCZg March 9th 2019, 11:03am |
|
@TickerReport Chembio Diagnostics $CEMI Posts Quarterly Earnings Results, Misses Expectations By $0.04 EPS https://t.co/hWsGB0SS0a March 8th 2019, 2:03pm |
 |
@ThisLincolnian Chembio Diagnostics $CEMI Announces Earnings Results, Misses Estimates By $0.04 EPS https://t.co/qg50AVsnHc March 8th 2019, 12:03pm |
|
@marketexclusive $CEMI CHEMBIO DIAGNOSTICS, INC. (NASDAQ:CEMI) Files An 8-K Results of Operations and Financial Condition https://t.co/sBQjJ98yYv March 8th 2019, 9:03am |
|
@StockTexts $CEMI Chembio Diagnostics, Inc. SEC Filing: Form 8-K https://t.co/jBDBeYLkx9 March 8th 2019, 9:03am |
 |
@ConsumerFeed Chembio Diagnostics Inc updates FY 2019 guidance to EPS & revenue guidance to $36-40 million. https://t.co/Y2k4puN6FN $CEMI #CEMI March 8th 2019, 3:03am |
 |
@SeekingAlpha $CEMI - Chembio Diagnostics, Inc. (CEMI) CEO John Sperzel on Q4 2018 Results - Earnings Call Transcript https://t.co/b0ixflY0Pr March 7th 2019, 10:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.